Document is current
Any future updates will be listed below
-
Authors
Miettinen, Tomi https://orcid.org/0000-0002-8896-4431
Myllymaa, Katja
Muraja-Murro, Anu
Westeren-Punnonen, Susanna
Hukkanen, Taina
Töyräs, Juha
Lappalainen, Reijo
Mervaala, Esa
Sipilä, Kirsi
Myllymaa, Sami
-
Funding
Funding for this research was provided by:
Tekes (40047/14)
Academy of Finland (313697)
Kuopion Yliopistollinen Sairaala (5041739, 5041764, 5041761, 5041770)
Hengityssairauksien Tutkimussäätiö (-)
Runar Bäckström foundation (-)
Instrumentariumin Tiedesäätiö (-)
Pohjois-Savon Rahasto (-)
- License Information
-
More Information
Article History
Received: 28 February 2019
Revised: 25 July 2019
Accepted: 2 August 2019
First Online: 12 August 2019
Compliance with ethical standards
: K. Myllymaa, J. Töyräs, R. Lappalainen, E. Mervaala and S. Myllymaa are amongst the original developers of the frontal electrode set used in this study, which was patented by the University of Eastern Finland. The patent was sold to Mega Electronics Oy, later Bittium Biosignals Oy (Kuopio, Finland) and the concept of the electrode set has been used as the basis for a new commercially available BrainStatus emergency EEG electrode set. The University of Eastern Finland and the previously named original developers have a royalty agreement for the sales of BrainStatus with Bittium Biosignals Oy.
: All procedures performed in studies involving human participants were conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol was reviewed by the Research Ethics Committee of the Hospital District of Northern Savo, Kuopio, Finland (favorable opinion: 34/2013) and permission for the research use of frontal electrode set was obtained from the National Supervisory Authority for Welfare and Health (Valvira, 220/2013). Informed consent was obtained from all individual participants included in the study.
